Details for Patent: 8,192,722

Which drugs does patent 8,192,722 protect, and when does it expire?

Patent 8,192,722 protects OPANA ER and is included in one NDA.

This patent has one hundred and seventy-six patent family members in thirty-one countries.

Summary for Patent: 8,192,722

Title:	Abuse-proof dosage form
Abstract:	The invention relates to a dosage form that is thermoformed without discoloration and is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse. The invention also relates to a corresponding method for producing said dosage form.
Inventor(s):	Arkenau-Maric; Elisabeth (Koln, DE), Bartholomaus; Johannes (Aachen, DE), Kugelmann; Heinrich (Aachen, DE)
Assignee:	Grunenthal GmbH (Aachen, DE)
Application Number:	12/140,665
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,192,722
Patent Claim Types: see list of patent claims	Compound; Dosage form; Composition; Process;

Drugs Protected by US Patent 8,192,722

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-001	Dec 9, 2011		DISCN	Yes	No			Y
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-002	Dec 9, 2011		DISCN	Yes	No			Y
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-003	Dec 9, 2011		DISCN	Yes	No			Y
Endo Pharms	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201655-004	Dec 9, 2011		DISCN	Yes	No			Y

International Family Members for US Patent 8,192,722

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	045352
Argentina	045353
Argentina	046994
Argentina	049083